Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 7.96 % |
3 Month Return | + 1.43 % |
1 Year Return | -7.05 % |
Market Stats | |
Previous Close | ₹111.26 |
Open | ₹111.26 |
Volume | 1.07L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹546.31Cr |
P/E Ratio | 33.61 |
PEG Ratio | -80.03 |
Market Cap | ₹546.31 Cr |
P/B Ratio | 2.01 |
EPS | 3.54 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 7.87 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹546.31 Cr | 17.12% | 0.66 | ₹17 Cr | ₹367 Cr | |
NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
Organisation | Zim Laboratories Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Zim Laboratories Ltd
ZIM Laboratories' Accrual Ratio Indicates Lower Free Cash Flow - 21 May, 2024
ZIM Lab Reports Increase in Net Sales and Quarterly Net Profit - 17 May, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 82.82 Cr → 93.46 Cr (in ₹), with an average increase of 11.4% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 0.9 Cr → 2.38 Cr (in ₹), with an average increase of 62.2% per quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 138.2%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 62.8%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 66.63% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 33.26% of holdings in Sep 2024 quarter
Price Dip
In the last 3 years, ZIMLAB stock has moved down by -2.4%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 33.26% | 0.00 | |
Foreign Institutions | 0% | 33.33 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 66.63% | 0.01 | |
Others | 0.1% |
Zim Laboratories Ltd in the last 5 years
Lowest (6.12x)
June 11, 2018
Today (33.61x)
December 19, 2024
Industry (56.23x)
December 19, 2024
Highest (198.80x)
July 1, 2021
Zim Laboratories Ltd’s net profit fell -42.65% since last year same period to ₹2.38Cr in the Q2 2024-2025. On a quarterly growth basis, Zim Laboratories Ltd has generated 164.44% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.38%.
Read More about DividendsBearish
Neutral
Bullish
Zim Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Zim Laboratories Ltd (ZIMLAB) share price today is ₹108.77
Zim Laboratories Ltd is listed on NSE
Zim Laboratories Ltd is listed on BSE
PE Ratio of Zim Laboratories Ltd is 33.61
PE ratio = Zim Laboratories Ltd Market price per share / Zim Laboratories Ltd Earnings per share
Today’s traded volume of Zim Laboratories Ltd(ZIMLAB) is 1.07L.
Today’s market capitalisation of Zim Laboratories Ltd(ZIMLAB) is ₹546.31Cr.
Zim Laboratories Ltd(ZIMLAB | Price |
---|---|
52 Week High | ₹131.4 |
52 Week Low | ₹89.5 |
Zim Laboratories Ltd(ZIMLAB) share price is ₹108.77. It is down -17.22% from its 52 Week High price of ₹131.4
Zim Laboratories Ltd(ZIMLAB) share price is ₹108.77. It is up 21.53% from its 52 Week Low price of ₹89.5
Zim Laboratories Ltd(ZIMLAB | Returns |
---|---|
1 Day Returns | -2.49% |
1 Month Returns | 7.96% |
3 Month Returns | 1.43% |
1 Year Returns | -7.05% |